Clinical Trials Directory

Trials / Completed

CompletedNCT04793230

Nasolacrimal Sac Biopsy in Endoscopic Dacryocystorhinostomy

Predictive Value of Nasolacrimal Sac Biopsy in Endoscopic Dacryocystorhinostomy

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

During dacryocystorhinostomy (DCR), the lacrimal sac wall biopsy is not routinely performed, but it is recommended if there is a suspicion of underlying disease other than preoperatively or intraoperatively chronic inflammation. We aimed to evaluate the utility of the histopathology examination of fifty patients in AlAzhar Hospitals to put recommendation for histopathology examination of such cases.

Detailed description

Most of patient with epiphora have different causes of nasolacrimal duct obstruction . This study aims to examine how important routine lacrimal sac biopsy is during endoscopic dacryocystorhinostomy surgery. The study included 50 patients with chronic unilateral epiphora. All patients underwent endoscopic dacryocystorhinostomy with nasolacrimal duct biopsy. Histopathologic analysis was performed for each specimen to assess the nature of the pathology.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTbiopsyingThe procedure was carried out under general or local anesthesia. An otolaryngologist conducts the endoscopic intranasal operation, while an eye surgeon removes tissue from the sac and lacrimal tubes using lacrimal probes passed through the canaliculi.

Timeline

Start date
2019-01-01
Primary completion
2020-12-30
Completion
2021-03-09
First posted
2021-03-11
Last updated
2021-03-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04793230. Inclusion in this directory is not an endorsement.